Coenzyme Q10 as a possible treatment for neurodegenerative diseases

Free Radical Research

Volumn 36, Issue 4, 2002, Pages 455-460

  Beal, M Flint ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Free radicals; Huntington's; Parkinson's

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 NITROPROPIONIC ACID; ANTIOXIDANT; CARRIER PROTEIN; MALONIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; REMACEMIDE; UBIDECARENONE; DRUG DERIVATIVE; UBIQUINONE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BRAIN ATROPHY; BRAIN DISEASE; BRAIN INJURY; CLINICAL STUDY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG POTENTIATION; DRUG USE; ELECTRON TRANSPORT; HUNTINGTON CHOREA; MITOCHONDRION; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PARKINSON DISEASE; PATIENT CARE; STRIATE CORTEX; SURVIVAL; TRANSGENIC MOUSE; WEIGHT REDUCTION; ANIMAL; CELL PROTECTION; DIET SUPPLEMENTATION; HUMAN; REVIEW;

ANIMALIA; MUS MUSCULUS;

ANIMALS; ANTIOXIDANTS; CYTOPROTECTION; DIETARY SUPPLEMENTS; HUMANS; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; UBIQUINONE;

EID: 0036525567     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760290021315     Document Type: Article

References (61)

1. Bayer, R.E. (1992) "An analysis of the role of coenzyme Q in free radical generation and as an antioxidant", Biochem. Cell. Biol. 70, 390-403.
2. Dallner, G. and Sindelar, P.J. (2000) "Regulation of ubiquinone metabolism", Free Radic. Biol. Med. 29, 285-294.
3. Noack, H., Kube, U. and Augustin, W. (1994) "Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria", Free Radic. Res. 20, 375-386.
4. Lass, A. and Sohal, R.S. (1998) "Electron transport-linked ubiquinone-dependent recycling of a-tocopherol inhibits autooxidation of mitochondrial membranes", Arch. Biochem. Biophys. 352, 229-236.
5. Ogasahara, S., Engel, A.G., Frens, D. and Mack, D. (1989) "Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy", Proc. Natl. Acad. Sci. USA 86, 2379-2382.
6. 10 deficiency", Neurology 48, 1238-1243.
7. 10 deficiency", J. Neurol. Sci. 156, 41-46.
8. 10 deficiency", Lancet 356, 391-395.
9. Abe, K., Fujimura, H., Nishikawa, Y., Yorifuki, S., Mezaki, T., Hirono, N., Nishitani, N. and Kameyama, M. (1991) "Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)", Acta Neurol. Scand. 83, 356-359.
10. 10", Neurology 38, 892-899.
11. 10 and idebenone", J. Neurol. Sci. 90, 263-271.
12. 31P NMR study", Neurology 39, 399-403.
13. 10 therapy", J. Neurol. 245, 681-685.
14. 10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorus magnetic resonance spectroscopy", Cell. Mol. Biol. 43, 741-749.
15. 10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry", J. Neurol. Sci. 162, 65-68.
16. 10 and multiple vitamins in a patient with bilateral optic neuropathy", Mov. Disorders 14, 855-859.
17. Bruno, V, Battaglia, G., Copani, A., Sortino, M.A., Canonico, P.L. and Nicoletti, F. (1994) "Protective action of idebenone against excitotoxic degeneration in cultured cortical neurons", Neurosci. Lett. 178, 193-196.
18. Ikejiri, Y., Mori, E., Ishii, K., Nishimoto, K., Yasuda, M. and Sasaki, M. (1996) "Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS", Neurology 47, 583-585.
19. 31P-MRS study", J. Neurol. Sci. 148, 25-31.
20. Rustin, P., Von Kleist-Retzow, J.C., Chantrel-Groussard, K., Sidi, D., Munnich, A. and Rotig, A. (1999) "Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study", Lancet 354, 477-479.
21. Landi, L., Fiorentini, D., Galli, M.C., Segura-Aguilar, J. and Beyer, R.E. (1997) "DT-diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function", Free Radic. Biol. Med. 22, 329-335.
22. Edlund, C., Holmberg, K., Dallner, G., Norrby, E. and Kristensson, K. (1994) "Ubiquinone-10 protects neurons from virus-induced degeneration", J. Neurochem. 63, 634-639.
23. Favit, A., Nicoletti, F., Scapagnini, U. and Canonico, P.L. (1992) "Ubiquinone Protects cultured neurons against spontaneous and excitotoxin-induced degeneration", J. Cereb. Blood Flow Metab. 12, 638-645.
24. 10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate", Annals Neurol. 36, 882-888.
25. 10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases", Mol. Asp. Med. 18, s169-s179.
26. 10", Neurosci. Lett. 177, 58-62.
27. 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects", Proc. Natl. Acad. Sci. USA 95, 8892-8897.
28. 10 on biochemical and morphological changes in experimental ischemia in the rat brain", Brain Res. Bull. 53, 399-407.
29. 10 in the rat following its oral and intraperitoneal administration", Drug Metab. Dispos. 20, 423-427.
30. Zhang, Y., Turunen, M. and Appelkvist, E.-L. (1996) "Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of α-tocopherol into rat organs and cells", J. Nutr. 126, 2089-2097.
31. 10", Free Radic. Biol. Med. 26, 1375-1382.
32. 10 and vitamin E alter the status of these compounds in rat tissues and mitochondria", J. Nutr. 130, 2343-2348.
33. Battino, M., Gorini, A., Villa, R.F., Genova, M.L., Bovina, C., Sassi, S., Littarru, G.P. and Lenaz, G. (1995) "Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat", Mech. Ageing Dev. 78, 173-187.
34. Beyer, R.E., Burnett, B.-A., Cartwright, K.J., Edington, D.E., Falzon, M.J., Kreitman, K.R., Kuhn, T.W., Ramp, B.J., Rhee, S.Y.S., Rosenwasser, M.J., Stein, M. and An, L.C.-I. (1985) "Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat", Mech. Ageing Dev. 32, 267-281.
35. Kalen, A., Appelkvist, E.-L. and Daliner, G. (1989) "Age-related changes in the lipid compositions of rat and human tissues", Lipids 24, 579-584.
36. Kagan, V.E., Serbinova, E.A., Koynova, G.M., Kitanova, S.A., Tyurin, V.A., Stoytchev, T.S., Quinn, P.J. and Packer, L. (1990) "Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes", Free Radic. Biol. Med. 9, 117-126.
37. Poderoso, J.J., Carreras, M.C., Schopfer, F., Lisdero, C.L., Riobo, N.A., Giulivi, C., Boveris, A.D., Boveris, A. and Cadenas, E. (1999) "The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance", Free Radic. Biol. Med. 26, 925-935.
38. Kagan, V., Serbinova, E. and Packer, L. (1990) "Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling", Biochem. Biophys. Res. Commun. 169, 851-857.
39. Maguire, J.J., Kagan, V., Ackrell, B.A., Serbinova, E. and Packer, L. (1992) "Succinate-ubiquinone reductase linked recycling of α-tocopherol in reconstituted systems and mitochondria: requirement of reduced ubiquinone", Arch. Biochem. 292, 47-53.
40. Mukai, K., Morimoto, H., Kikuchi, S. and Nagaoka, S. (1993) "Kinetic study of free-radical-scavenging action of biological hydroquinones (reduced forms of ubiquinone, vitamin K and tocopherol quinone) in solution", Biochim. Biopys. Acta 1157, 313-317.
41. Shi, H., Noguchi, N. and Niki, E. (1999) "Comparative study on dynamics of antioxidative action of α-tocopheryl hydroquinone, ubiquinol, and α-tocopherol against lipid peroxidation", Free Radic. Biol. Med. 27, 334-346.
42. Kozlov, A.V, Gille, L., Staniek, K. and Nohl, H. (1999) "Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone", Arch. Biochem. Biophys. 363, 148-154.
43. Gotz, M.E., Dirr, A., Burger, R., Janetzky, B., Weinmuller, M., Chan, W.W., Chen, S.C., Reichmann, H., Rausch, W.D. and Riederer, P. (1994) "Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate", Eur. J. Pharmacol. 266, 291-300.
44. Echtay, K.S., Winkler, E. and Klingenberg, M. (2000) "Coenzyme Q is an obligatory cofactor for uncoupling protein function", Nature 408, 609-613.
45. Echtay, K., Winkler, E., Frischmuth, K. and Klingenberg, M. (2001) "Uncoupling protein 2 and 3 are highly active H+ transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone)", Proc. Natl. Acad. Sci. USA 98, 1416-1421.
46. Ricquier, D. and Bouillaud, F. (2000) "The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP", Biochem. J. 345, 161-179.
47. 10 enrichment decreases oxidative DNA damage in human lymphocytes", Free Radic. Biol. Med. 27, 1027-1032.
48. Schulz, J.B., Matthews, R.T., Henshaw, D.R. and Beal, M.F. (1996) "Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases", Neuroscience 71, 1043-1048.
49. Beal, M.F., Brouillet, E., Jenkins, B.G., Ferrante, R.J., Kowall, N.W., Miller, J.M., Storey, E., Srivastava, R., Rosen, B.R. and Hyman, B.T. (1993) "Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid", J. Neurosci. 13, 4181-4192.
50. Brouillet, E., Hantraye, P, Ferrante, R.J., Dolan, R., Leroy-Willig, A., Kowall, N.W. and Beal, M.F. (1995) "Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates", Proc. Natl. Acad. Sci. USA 92, 7105-7109.
51. Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Hentati, A., Kwon, Y.W., Deng, H.-X., Chen, W., Zhai, P, Sufit, R.L. and Siddique, T. (1994) "Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation", Science 264, 1772-1775.
52. Kong, J. and Xu, Z. (1998) "Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1:, J. Neurosci. 18, 3241-3250.
53. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. and Bates, G.F. (1996) "Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice", Cell 87, 493-506.
54. Ferrange, R.J., Andreassen, O.A., Jenkins, B.G., Dedeoglu, A., Kuemmerle, S., Kubilus, J.K., Kaddurah-Daouk, R., Hersch, S.M. and Beal, M.F. (2000) "Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease", J. Neurosci. 20, 4389-4397.
55. 10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects", Annals Neurol. 42, 261-264.
56. 10", Annals Neurol. 41, 160 -165.
57. 10 tolerability in Huntington's disease", Mov. Disorders 11, 321-323.
58. 10 in patients with Alzheimer's disease", J. Neural Transm. 107, 233-239.
59. 10 in patients with amyotrophic lateral sclerosis", J. Neural Transm. 107, 1021-1026.
60. 10 in Parkinson's disease", J. Neural Transm. 107, 41-48.
61. 10 in patients with Parkinson's disease", J. Neural Transm. 107, 177-181.